A 3-week dietary bioequivalence study in preweaning farm piglets of two sources of docosahexaenoic acid produced from two different organisms

Food and Chemical Toxicology

Volumn 65, Issue , 2014, Pages 43-51

  Fedorova Dahms, Irina ^a   Thorsrud, Bjorn A ^b   Bailey, Eileen ^a   Salem, Norman ^a  

^a DSM NUTRITIONAL PRODUCTS   (United States)

^b MPI RESEARCH   (United States)

Author keywords

Arachidonic acid; DHASCO; Docosahexaenoic acid; Infant nutrition; Piglet

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL TISSUE; ARTICLE; ARTIFICIAL MILK; AUTOPSY; BIOACCUMULATION; BIOEQUIVALENCE; BLOOD CLOTTING; BODY FAT DISTRIBUTION; BODY GROWTH; BODY WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; FARM ANIMAL; FAT CONTENT; FAT INTAKE; FATTY ACID ANALYSIS; FEMALE; FOOD INTAKE; HEMATOLOGY; LIPID BLOOD LEVEL; LIPID COMPOSITION; MALE; NONHUMAN; PIGLET; TREATMENT DURATION; URINALYSIS; WEANING; CLINICAL CHEMISTRY; CONCENTRATION (PARAMETERS); DIETARY INTAKE; GROWTH RATE; MICROSCOPY; NUTRITIONAL ASSESSMENT;

ARACHIDONIC ACID; DHASCO; DOCOSAHEXAENOIC ACID; INFANT NUTRITION; PIGLET;

ANIMALS; DOCOSAHEXAENOIC ACIDS; FEMALE; MALE; MICROALGAE; SWINE; THERAPEUTIC EQUIVALENCY; TISSUE DISTRIBUTION; WEANING;

EID: 84891949215     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.12.008     Document Type: Article

References (31)

1. Arterburn L., Bailey Hall E., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 2006, 83(Suppl.):S1467-S1476.
2. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 37:911.
3. Birch E.E., Hoffman D.R., Uauy R., Birch D.G., Prestidge C. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Ped. Res. 1998, 44:201-209.
4. Brenna J.T., Varamini B., Jensen R.G., Diersen-Schade D.A., Boettcher J.A., Arterburn L.M. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am. J. Clin. Nutr. 2007, 85:1457-1464.
5. Carlson S.E., Werkman S.H., Rhodes P.G., Tolley E.A. Visual-acuity development in healthy preterm infants: effect of marine-oil supplementation. Am. J. Clin. Nutr. 1993, 58:35-42.
6. Carlson S.E., Werkman S.H., Peeples J.M., Cooke R.J. Arachidonic acid status correlates with first year growth in preterm infants. Proc. Natl. Acad. Sci. USA 1993, 90:1073-1077.
7. Edwards D., Berry J.J. The efficiency of simulation-based multiple comparisons. Biometrics 1987, 43:913-928.
8. FAO/WHO, 2008. Joint FAO/WHO Expert Consultation on Fats and Fatty Acids in Human Nutrition. Interim Summary of Conclusions and Dietary Recommendations on Total Fat & Fatty Acids. November 2008. http://www.who.int/entity/nutrition/topics/FFA_summary_rec_conclusion.pdf.
9. Fedorova-Dahms I., Marone P.A., Bauter M., Ryan A.S. Safety evaluation of DHA-rich algal oil from Schizochytrium sp. Food Chem. Toxicol. 2011, 49:3310-3318.
10. Flamm E.G. Neonatal animal testing paradigms and their suitability for testing infant formula. Toxicol. Mech. Methods 2013, 23:57-67.
11. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissue. J. Biol. Chem. 1957, 226:497-509.
12. FDA, 2001. Substances Affirmed as Generally Recognized as Safe: DHASCO (Docosahexaenoic Acid-Rich Single-Cell Oil) and ARASCO (Arachidonic Acid-Rich Single-Cell Oil). GRN No. 41.
13. FDA, 2004. Substances Affirmed as Generally Recognized as Safe: DHA-rich Algal Oil (Schizochytrium sp.). GRN No. 137.
14. Hoffman D.R., Boettcher J.A., Diersen-Schade D.A. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic acid and arachidonic acid supplementation: a review of randomized controlled trials. Prostaglandins Leukot. Essent. Fatty Acids 2009, 81:151-158.
15. Koletzko B., Cetin I., Brenna J.T. Dietary fat intakes for pregnant and lactating women. Br. J. Nutr. 2007, 98:873-877.
16. IOM (Institute of Medicine), 2004. Testing ingredients with preclinical studies. In: Infant Formula: Evaluating the Safety of New Ingredients. The National Academies Press, Washington, D.C., pp. 70-97.
17. Makrides M., Neumann M., Simmer K., Pater J., Gibson R. Are long-chain polyunsaturated fatty acids essential nutrients in infancy?. Lancet 1995, 345:1463-1468.
18. Martek, 2010. Expert Panel Report Concerning the Generally Recognized as Safe (GRAS) Status of Algal Oil derived from a New Production Strain of Schizochytrium sp. Martek Biosciences Corporation. Internal Document.
19. Martinez M. Developmental profiles of polyunsaturated fatty acids in the brain of normal infants and patients with peroxisomal disease: severe deficiency of docosahexaenoic acid in Zellweger's and pseudo-Zellweger's syndromes. World Rev. Nutr. Diet. 1991, 66:87-102.
20. Merritt R.J., Auestad N., Kruger C., Buchanan S. Safety evaluation of sources of docosahexaenoic acid and arachidonic acid for use in infant formulas in newborn piglets. Food Chem. Toxicol. 2003, 41:897-904.
21. Morrison W.R., Smith L.M. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J. Lipid Res. 1964, 5:600-608.
22. O'Connor D.L., Hall R., Adamkin D., Auestad N., Castillo M., Connor W.E., Connor S.L., Fitzgerald K., Groh-Wargo S., Hartmann E.E., Jacobs J., Janowsky J., Lucas A., Margeson D., Mena P., Neuringer M., Nesin M., Singer L., Stephenson T., Szabo J., Zemon V. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics 2001, 108:359-371.
23. Ratledge, C., 2003. An Opinion on the Safety Data for the DHA-rich oil from Schizochytrium sp., also known as DHASCO-S. Martek Biosciences, Columbia, MD. Internal Document.
24. Ryan A.S., Zeller S.G., Nelson E.B. Safety evaluation of single cell oils and the regulatory requirements for use as food ingredients. Single Cell Oils 2010, 317-350. AOCS Press, Champaign, Illinois. Z. Cohen, C. Ratledge (Eds.).
25. Salem N. Omega-3 fatty acids: molecular and biochemical aspects. New Protective Roles for Selected Nutrients 1989, 109-228. Alan R. Liss, Inc., New York. G.A. Spiller, J. Scala (Eds.).
26. Salem N., Litman B., Kim H.-Y., Gawrisch K. Mechanism of action of docosahexaenoic acid in the nervous system. Lipids 2001, 36:945-959.
27. Shirai N., Suzuki H., Wade S. Direct methylation from mouse plasma and from liver and brain homogenates. Anal. Biochem. 2005, 343:48-53.
28. Thorsrud, B.A., Aulbach, A.D., Faqi, A.S., 2012. Neonatal Piglets as an Animal Model to Evaluate New Ingredients in Infant Formula. Poster Abstract #1112. Society of Toxicology.
29. Trahms C.M., McKean K.N. Nutrition during infancy. Krause's Food & Nutritional Therapy 2007, 199-221. Elsevier. L.K. Mahan, S. Escott-Stump (Eds.).
30. Tyburczy C., Kothapalli K.S.D., Park W.J., Blank B.S., Bradford K.L., Zimmer J.P., Butt C.M., Salem N., Brenna J.T. Heart arachidonic acid is uniquely sensitive to dietary arachidonic acid and docosahexaenoic acid content in domestic piglets. Prostaglandins Leukot. Essent. Fatty Acids 2011, 85:335-343.
31. Zeller S.G. Safety evaluation of single cell oils and the regulatory requirements for use as food ingredients. Single Cell Oils 2005, 161-181. AOCS Press. Z. Cohen, C. Ratledge (Eds.).